Repligen | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Agilent USD 856M 52M 2024-04
Align Technology USD 697.82M 28.29M 2024-03
Bio Techne USD 204.6M 19.41M 2024-03
BioMarin Pharmaceutical USD 523.65M 12.92M 2024-03
Bristol-Myers Squibb USD 8.93B 163M 2024-03
Bruker USD 352.8M 77.5M 2024-03
Catalent USD 229M 58M 2024-03
Charles River Laboratories USD 344.84M 25.91M 2024-03
Danaher USD 3.49B 292M 2024-03
Dentsply International USD 506M 16M 2024-03
Exact Sciences USD 467.42M 7.6M 2024-03
General Electric USD 4.43B 298M 2024-03
Henry Schein USD 1.01B 87M 2024-03
Illumina USD 667M 7M 2024-03
IQVIA Holdings USD 1.29B 97M 2024-03
Mettler Toledo International USD 548.13M 3.5M 2024-03
Myriad Genetics USD 137.6M 2.6M 2024-03
Patterson Companies USD 351.01M 11.98M 2024-01
Pfizer USD 11.5B 3.92B 2024-03
Repligen USD 74.96M 7.35M 2024-03
Revvity USD 355.05M 28.43M 2024-03
Standard Biotools USD 24.19M 10.83M 2024-03
Thermo Fisher Scientific USD 4.2B 291M 2024-03
Waters USD 501.11M 80.83M 2023-12
West Pharmaceutical Services USD 230.2M 48M 2024-03



Repligen Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.